Pharmaceutical & Healthcare Annual Deals Analysis Market To Witness Huge Growth By 2026 – Press Release

[ad_1]

Pharmaceutical & Healthcare Annual Deals Analysis Market

Pharmaceutical & Healthcare Annual Deals Analysis Market

HTF Market Intelligence released a new research Study of 154 pages on title ‘Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends – 2019’ with in-depth analysis, forecast and business moves. The study covers key regions that includes North America, Europe, Asia-Pacific, South America, Middle East and Africa.

Request a sample report @ https://www.htfmarketreport.com/sample-report/2607302-pharmaceutical-healthcare-annual-deals-analysis

Summary

Global Data’s “Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends – 2019” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in the year 2019. The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Data presented in this report is derived from Global Data’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

– Analysis of the market trends for the pharmaceutical industry in the global arena.
– Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women’s health segments.
– Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
– Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
– Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
– Analysis of partnership and licensing deals based on clinical stage of development of products.
– Summary of the pharmaceutical deals globally in the six months.
– Information on the top deals happened in the pharmaceutical industry.
– Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
– League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Buy full copy of the report @ https://www.htfmarketreport.com/buy-now?format=1&report=2607302

Reasons to Buy

– Enhance your decision making capability in a more rapid and time sensitive manner.
– Find out the major deal performing segments for investments in your industry.
– Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
– Identify companies that are aggressively looking to raise capital in the market
– Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
– Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
– Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
– Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
– Identify growth segments and opportunities in each region within the industry.
– Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Companies Mentioned in the Report

Enquire for Customization Available @ https://www.htfmarketreport.com/enquiry-before-buy/2607302-pharmaceutical-healthcare-annual-deals-analysis

Table of Contents
1.1. List of Tables 6
1.2. List of Figures 9
2. Deal Values In Pharmaceutical & Healthcare Industry Increased In 2019 11
2.1. Pharmaceutical & Healthcare, Deals Summary, 2019 11
3. Pharmaceutical & Healthcare, Global, Deals Summary 16
3.1. Pharmaceutical & Healthcare, Global, Deals Analysis, 2019 16
4. Pharmaceuticals & Healthcare, Global, Deal Summary, by Type 29
5. Pharmaceuticals & Healthcare, Global, Deal Summary, By Market 89
6. Pharmaceuticals & Healthcare, Deal Summary, By Geography 126
7. Pharmaceuticals & Healthcare, Global, Top Financial Advisors 149
7.1. Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2019 149
7.2. Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2019 151
8. Further Information 153
8.1. Methodology 153
8.2. About GlobalData 153
8.3. Contact Us 154
8.4. Disclosure information 154
8.5. Disclaimer 1541.1. List of Tables
Table 1: Pharmaceutical & Healthcare, Global, Deals Summary, Number of Deals and Deal Value (US$ m), 2015 – 2019 17
Table 2: Pharmaceuticals & Healthcare, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2019-Q4 2019 19
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), 2019 21
Table 4: Pharmaceuticals & Healthcare, Top Deals, Global, 2019 22
Table 5: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), 2015 – 2019 30
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2019-Q4 2019 31
Table 7: Pharmaceuticals & Healthcare, Global, Top M&A Deals, 2019 32
Table 8: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, 2019 33
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), 2015 – 2019 35
Table 10: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2019-Q4 2019 36
Table 11: Pharmaceuticals & Healthcare, Global, IPO Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2015 – 2019 37
Table 12 Pharmaceuticals &

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2607302-pharmaceutical-healthcare-annual-deals-analysis

PR & Marketing Manager
HTF Market Intelligence Consulting Pvt. Ltd.
1-206-317-1218

Connect with us at LinkedIn | Facebook | Twitter

About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

This release was published on openPR.

[ad_2]